Atherotech Diagnostics president and CEO wins Ernst & Young Entrepreneur Of The Year Award
Atherotech Diagnostics Lab's president and CEO, Michael V. Mullen, has been awarded the Ernst & Young (EY) Entrepreneur of the Year Southeast programme award for excellence in healthcare and life sciences. In May, Mullen was named one of the 24 finalists for the award, which recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. The Southeast programme includes nominees from Alabama, Georgia, North Carolina, South Carolina and Tennessee, and eight categories with three nominees in each. The award gala was held at the InterContinental Buckhead Hotel in Atlanta, Georgia on Thursday, 26 June.
"I am truly honoured to be named the Southeast EY Entrepreneur of the Year for excellence in health care and life sciences," said Mullen. "Behind every leader is a great team of people and I think this is a true testament to Atherotech's commitment to delivering the most effective and cutting-edge technologies to ultimately reduce or eliminate heart disease. I look forward to many more successful years at Atherotech and thank EY for recognizing me with this amazing honour."
Mullen joined Atherotech Diagnostics more than 10 years ago, serving in various roles, before being appointed to president and CEO in 2009. Prior to his role at Atherotech, Mullen began his career as a lab-technician at the University of Alabama-Birmingham and as an accountant for EY in the healthcare division. Mullen believes his EY experience prepared him for high-pressure situations and helped him lead the development and explosive growth that Atherotech has experienced since he took control. While at Atherotech, Mullen has dedicated his time to expanding awareness of the company's leading product, the VAP+ Lipid Panel – a cholesterol assessment to enable an effective and personalized approach to improve health outcomes and, ultimately, save lives. Under Mullen's leadership, Atherotech has focused on building credible evidence to strengthen the company's position within the cardiovascular disease space. Last year proved to be highly successful, with the company adding 200 new employees and growth topping 40% over each of the last 3 years. In addition, Atherotech was named one of the "Top Companies to Work For" by the Birmingham Alabama Magazine in 2012.
The EY Entrepreneur of the Year Program is now in its 28th year and has expanded globally to recognize company builders in over 145 cities and in more than 60 countries worldwide. Regional award winners are automatically eligible to compete at the national level. Award recipients in several national categories, as well as the National EY Entrepreneur of the Year Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on 15 November 2014.